Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT)
CUSIP: 76200L309
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 95,614,034
- Total 13F shares
- 2,211,492
- Share change
- -265,534
- Total reported value
- $31,558,000
- Price per share
- $14.27
- Number of holders
- 11
- Value change
- -$1,377,636
- Number of buys
- 6
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 76200L309?
CUSIP 76200L309 identifies RZLT - Rezolute, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76200L309:
Top shareholders of RZLT - Rezolute, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Genexine Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
91,300,933
|
$173,462,643 | — | 26 Apr 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.3%
|
1,212,122
|
$8,558,000 | — | 31 Mar 2021 | |
| CAXTON CORP |
13F
|
Company |
0.44%
|
424,243
|
$2,995,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.33%
|
312,336
|
$2,205,000 | — | 31 Mar 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.3%
|
288,000
|
$2,033,000 | — | 31 Mar 2021 | |
| BVF INC/IL |
13F
|
Company |
0.2%
|
190,815
|
$1,347,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
26,924
|
$190,000 | — | 31 Mar 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.02%
|
18,916
|
$134,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,611
|
$18,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
584
|
$4,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
475
|
$3,000 | — | 31 Mar 2021 |
Institutional Holders of Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT) as of Q2 2021
As of 30 Jun 2021,
Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,211,492 shares.
The largest 10 holders included
FEDERATED HERMES, INC., CAXTON CORP, CITADEL ADVISORS LLC, BVF INC/IL, NORTHERN TRUST CORP, VANGUARD GROUP INC, BlackRock Inc., UBS Group AG, PNC Financial Services Group, Inc., and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
10
Q2 2021 holders
11
Holder diff
1
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.